Robert O. Morgan, PhD

home / authors / robert-o-morgan-phd

Articles

April 15th 2019

Does Care Consultation Affect Use of VHA Versus Non-VHA Care?

Robert O. Morgan, PhD Shweta Pathak, PhD, MPH David M. Bass, PhD Katherine S. Judge, PhD Nancy L. Wilson, MSW Catherine McCarthy Jung Hyun Kim, PhD, MPH Mark E. Kunik, MD, MPH

Uncoordinated multisystem use is problematic for Veterans Health Administration (VHA) patients with dementia. The Partners in Dementia Care intervention is successful in changing the pattern of VHA versus non-VHA use.

October 23rd 2013

Utilization of Lymph Node Dissection, Race/Ethnicity, and Breast Cancer Outcomes

Zhannat Z. Nurgalieva, MD, PhD Luisa Franzini, PhD Robert O. Morgan, PhD Sally W. Vernon, PhD Xianglin L. Du, MD, PhD

The disparities in survival among node-positive breast cancer patients of African American and Hispanic heritage are not explained by nodal surgery utilization.

March 16th 2009

VHA Pharmacy Use in Veterans With Medicare Drug Coverage

Robert O. Morgan, PhD Laura A. Petersen, MD Jennifer C. Hasche, MSc Jessica A. Davila, PhD Margaret M. Byrne, PhD Nora I. Osemene, PharmD, MS Iris I. Wei, DrPH Michael L. Johnson, PhD

Greater Medicare managed care benefit levels reduce both the likelihood and magnitude of Veterans Health Administration pharmacy use by Medicare dually enrolled veterans.

August 1st 2000

Medicare Disenrollment and Selective Use of Medical Care: Osteoarthritis-Related Joint Replacement

Robert O. Morgan, PhD Beth A. Virnig, PhD Carolee A. DeVito, PhD Nancy A. Persily, MPH

April 1st 1998

Medicare HMOs: Who Joins and Who Leaves?

Beth A. Virnig, PhD, MPH Robert O. Morgan, PhD Carolee A. DeVito, PhD, MPH Nancy Alfred Persily, MPH